{"organizations": [], "uuid": "8340c1468fcd12e9ee48822504e91fbd0483c97b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.pharmamedtechbi.com", "main_image": "", "site_section": "http://feeds.feedburner.com/PharmaBiotechFinancing", "section_title": "Pharma/Biotech Financing From Elsevier Business Intelligence", "url": "https://www.pharmamedtechbi.com/deals/201530569?elsca1=custom&elsca2=rss&elsca3=%3ftype%3dDeals%26advanced%3d(%2540industries%253d%2522Pharmaceuticals%2522)%2520and%2520(%2540industries%253d%2522Biotechnology%2522)%2520and%2520(%2540dealtype%253d%2522Financing%2522)", "country": "IL", "title": "Latest public offering nets $6.5mm for Delcath", "performance_score": 0, "site": "pharmamedtechbi.com", "participants_count": 0, "title_full": "Latest public offering nets $6.5mm for Delcath", "spam_score": 0.0, "site_type": "news", "published": "2015-07-21T02:40:00.000+03:00", "replies_count": 0, "uuid": "8340c1468fcd12e9ee48822504e91fbd0483c97b"}, "author": "", "url": "https://www.pharmamedtechbi.com/deals/201530569?elsca1=custom&elsca2=rss&elsca3=%3ftype%3dDeals%26advanced%3d(%2540industries%253d%2522Pharmaceuticals%2522)%2520and%2520(%2540industries%253d%2522Biotechnology%2522)%2520and%2520(%2540dealtype%253d%2522Financing%2522)", "ord_in_thread": 0, "title": "Latest public offering nets $6.5mm for Delcath", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Latest public offering nets $6.5mm for Delcath Deal Date: Jul-01-2015 / Deal # 201530569 Executive Summary \nDelcath Systems Inc. (site-specific liver cancer treatment) netted $6.5mm through the public sale of 9.35mm units at $0.75 apiece. Each unit consisted of one common share, 0.75 of a five-year Series A warrant (exercisable at $0.87 for a share) and one 90-day Series B warrant (exercisable at $0.75 for one common share and 0.75 of a Series A warrant to buy another common share).", "external_links": [], "published": "2015-07-21T02:40:00.000+03:00", "crawled": "2015-07-21T14:33:26.025+03:00", "highlightTitle": ""}